NFKB1 and acute myeloid leukemia: Evidence has shown that NF-κB mediates chemoresistance in AML, based on its ability to induce anti-apoptotic genes such as BCL-2 (B-cell lymphoma 2) and BCL-XL (B-cell lymphoma-extra-large) [22].